Medtronic

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application.

In the last quarter the FDA gave the nod to 10 digital health devices.

Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin.

The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm.

Today at CES 2016 in Las Vegas, IBM Watson Health announced a new partnership with Under Armour, as well as sharing new information about its partnership with Medtronic, announced last April.

Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence.

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians.

Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver.

HHS appoints Susannah Fox as CTO: Just two weeks after our last hiring roundup, the Department of Health and Human Services announced that it had appointed longtime patient advocate and Pew Research alum Susannah Fox as its new CTO.

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone.